Opportunity Assessment Through the In-Licensor’s Lens: Growing Up Biotech Series
For an emerging biotech, a traditional commercial opportunity assessment is an essential part of the partnering process for a development-stage asset. This assessment provides an in-depth market understanding to support investment toward commercialization, and as such provides the ideal information for conversations with potential partners. However, there are additional, critical considerations that can ensure a well-rounded conversation.
This white paper is the third in our “Growing Up Biotech” series. The two previous papers (“Taking the Long View: Translating Science and Technology into Commercial Opportunity” and “To Partner or Not to Partner: Determining Your Commercialization Plan”) discussed the technical and transactional assessments required to identify the right type of partnership for a biotech’s asset or platform and overall business needs.